Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$2.58 +0.02 (+0.78%)
At close: Oct 1, 2026 · 4:00 PM EDT

Kiora Pharmaceuticals (KPRX) Non-Current Deffered Revenue (2025 - 2026)

Updated

Kiora Pharmaceuticals (KPRX) posted Non-Current Deffered Revenue of $1.25 million for Q2 2026, unchanged from $1.25 million a year earlier and unchanged from the prior quarter.

Analysis

Kiora Pharmaceuticals (KPRX) Non-Current Deffered Revenue (2025 - 2026) Analysis & Trends

Since Q2 2025, Kiora Pharmaceuticals has reported Non-Current Deffered Revenue for 5 quarters.

  • According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $1.25 million (Q1 2026), $1.25 million (Q4 2025) and $1.25 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Kiora Pharmaceuticals 15.81 Mn 15.81 Mn - 1.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.25 Mn
Mar 31, 2026 1.25 Mn
Dec 31, 2025 1.25 Mn
Sep 30, 2025 1.25 Mn
Jun 30, 2025 1.25 Mn
API Access

Kiora Pharmaceuticals Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=KPRX&period=max&api_key=YOUR_API_KEY